Turn Therapeutics Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
2
- Stock Symbol
-
TTRX
- Share Price
-
$10.13
- (As of Thursday Closing)
Turn Therapeutics General Information
Description
Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.
Contact Information
Website
www.turntherapeutics.comCorporate Office
- 250 North Westlake Boulevard
- Westlake Village, CA 91362
- United States
Corporate Office
- 250 North Westlake Boulevard
- Westlake Village, CA 91362
- United States
Turn Therapeutics Timeline
Turn Therapeutics Stock Performance
As of 12-Nov-2026, Turn Therapeutics’s stock price is $10.13. Its current market cap is $310M with 30.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $10.13 | $10.57 | $2.57 - $16.45 | $310M | 30.6M | 113K | -$0.43 |
Turn Therapeutics Financials Summary
As of 30-Sep-2026, Turn Therapeutics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 432,824 | 112,999 | ||
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (12,249) | (3,171) | (1,750) | (2,264) |
| Net Income | (12,773) | (3,194) | (1,768) | (2,292) |
| Total Assets | 16,350 | 12,162 | 2,049 | 2,014 |
| Total Debt | 6,231 | 80 | 121 | 25 |
Turn Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Turn Therapeutics Patents
Turn Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260041757-A1 | Thermostable mucosal vaccine compositions and methods | Pending | 09-Aug-2024 | ||
| WO-2026036093-A1 | Thermostable mucosal vaccine compositions and methods | Pending | 09-Aug-2024 | ||
| US-20250312296-A1 | Petrolatum-based phmb compositions and methods for the treatment of inflammatory skin disease | Pending | 20-Jun-2024 | ||
| US-20250387428-A1 | Petrolatum-based phmb compositions and methods for the treatment of inflammatory skin disease | Pending | 20-Jun-2024 | ||
| WO-2025264934-A2 | Petrolatum-based phmb compositions and methods for the treatment of inflammatory skin disease | Pending | 20-Jun-2024 | A61K31/785 |
Turn Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Turn Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Turn Therapeutics FAQs
-
When was Turn Therapeutics founded?
Turn Therapeutics was founded in 2015.
-
Where is Turn Therapeutics headquartered?
Turn Therapeutics is headquartered in Westlake Village, CA.
-
What is the size of Turn Therapeutics?
Turn Therapeutics has 2 total employees.
-
What industry is Turn Therapeutics in?
Turn Therapeutics’s primary industry is Drug Discovery.
-
Is Turn Therapeutics a private or public company?
Turn Therapeutics is a Public company.
-
What is Turn Therapeutics’s stock symbol?
The ticker symbol for Turn Therapeutics is TTRX.
-
What is the current stock price of Turn Therapeutics?
As of 12-Nov-2026 the stock price of Turn Therapeutics is $10.13.
-
What is the current market cap of Turn Therapeutics?
The current market capitalization of Turn Therapeutics is $310M.
-
What is Turn Therapeutics’s annual earnings per share (EPS)?
Turn Therapeutics’s EPS for 12 months was -$0.43.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
